Global Epigenetics Market Size, Share, Price, Trends, Growth,...

Global Epigenetics Market Size, Share, Price, Trends, Growth, Analysis, Report, Forecast 2021-2026

Posted 2023-01-18 08:54:07

The new report by Expert Market Research titled, ‘Global Epigenetics Market Growth, Share, Price, Size, Trend, Report and Forecast 2021-2026’, gives an in-depth analysis of the global epigenetics market, assessing the market based on its segments like products, application, end-use and major regions.

The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.

Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/epigenetics-market/requestsample

The key highlights of the report include:

Market Overview (2016-2026)

• Historical Market Size (2020): USD 877 million
• Forecast CAGR (2021-2026): 13.6%
• Forecast Market Size (2026): USD 1,908 million

The kits segment of the global epigenetics market has a significant market share based on product. The importance of kits in the overall epigenetic analysis process can be linked to this growth. Furthermore, this number is predicted to rise in the forecast period as a result of rising chronic sickness rates and rising senior population rates, both of which are highly susceptible to diseases such as cardiovascular disease and cancer.

Meanwhile, due to the increasing use of epigenetic research in the oncology area, the oncology segment is expected to have robust growth in terms of application. North America is expected to account for a sizable portion of the global epigenetics market. This increase can be ascribed to the region’s growing use of epigenetic research as well as increased spending in the healthcare sector’s expansion.

Industry Definition and Major Segments

Epigenetics is a new field of science that investigates how environmental factors regulate gene expression. Genes are activated and deactivated by cells in response to various environmental events, with no change in the organism’s underlying DNA structure, and predict which proteins are transcribed. These external environmental cues have the potential to change genes, which in turn can influence diseases. Furthermore, research has shown that many human disorders, such as autism, Parkinson’s disease, and breast cancer, are caused by the interplay of genetic variations and environmental exposure.

Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/epigenetics-market

By product, the market is divided into:

• Kits

• ChIP sequencing kits
• Bisulfite conversion kits
• Whole genome amplification kits
• 5-hmC & 5-mC analysis kits
• RNA sequencing kits
• Others

• Reagents

• Antibodies
• Magnetic beads
• Histones
• Buffers
• Primers
• Others

• Enzymes

• DNA polymerases
• DNA ligases
• Methyltransferases
• Acetylases
• Reverse transcriptase
• Others

• Instruments

• Next-generation sequencers
• qPCRs
• Mass spectrometers
• Sonicators
• Others

Based on end use, the market can be segmented into:

• Academics and Research Institutes
• Pharmaceutical and Biotechnology Companies
• Contract Research Organisations

On the basis of application, the industry can be categorised into:

• Oncology
• Solid tumours
• Liquid tumours
• Non-Oncology
• Metabolic diseases
• Infectious diseases
• Inflammatory diseases
• Cardiovascular diseases
• Others

The regional markets for the product include

• North America
• Europe
• The Asia Pacific
• Latin America
• The Middle East
• Africa

Market Trends

Cardiovascular illnesses are the biggest cause of death worldwide, according to WHO data, claiming the lives of more than 17.9 million people each year. Cardiovascular diseases are heart and blood vessel ailments caused by high-risk behaviours such as poor food, lack of physical activity, and substance addiction. Epigenetic research has discovered epigenetic biomarkers, which are a promising tool for the diagnosis and prognosis of a variety of cardiovascular disorders. Easy accessibility and feasibility in their detection procedures are two of their promising aspects, making them suitable for application in clinical interventions. This has a substantial impact on the market’s expansion.

Key Market Players

The major players in the market are Abcam Plc, Active Motif, Inc., Agilent Technologies, Inc., Diagenode S.A., QIAGEN GmbH and Others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.